Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Upfront of prophylaxis and treatment of GVHD].
Sugita J, Teshima T. Sugita J, et al. Rinsho Ketsueki. 2013 Feb;54(2):156-66. Rinsho Ketsueki. 2013. PMID: 23470822 Review. Japanese. No abstract available.
Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation.
Hayase E, Fujimoto K, Mitsuhashi T, Hatanaka Y, Yoshida M, Takemura R, Iwasaki J, Shiratori S, Sugita J, Kondo T, Tanaka J, Imamura M, Matsuno Y, Teshima T. Hayase E, et al. Among authors: sugita j. Transplantation. 2014 Jan 15;97(1):e1-3. doi: 10.1097/01.TP.0000437912.60638.23. Transplantation. 2014. PMID: 24374766 No abstract available.
[Control of graft-versus-host disease].
Sugita J, Teshima T. Sugita J, et al. Rinsho Ketsueki. 2014 Feb;55(2):170-6. Rinsho Ketsueki. 2014. PMID: 24598183 Review. Japanese. No abstract available.
Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M, Hashino S, Onozawa M, Shigematsu A, Sugita J, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T. Takahata M, et al. Among authors: sugita j. Transpl Infect Dis. 2014 Oct;16(5):797-801. doi: 10.1111/tid.12283. Epub 2014 Aug 25. Transpl Infect Dis. 2014. PMID: 25154638
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
Shiratori S, Fujimoto K, Nishimura M, Hatanaka KC, Kosugi-Kanaya M, Okada K, Sugita J, Shigematsu A, Hashimoto D, Endo T, Kondo T, Abe R, Hashino S, Matsuno Y, Shimizu H, Teshima T. Shiratori S, et al. Among authors: sugita j. Hematol Oncol. 2016 Mar;34(1):9-16. doi: 10.1002/hon.2162. Epub 2014 Oct 14. Hematol Oncol. 2016. PMID: 25312300 Free article.
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning.
Sugita J, Kawashima N, Fujisaki T, Kakihana K, Ota S, Matsuo K, Miyamoto T, Akashi K, Taniguchi S, Harada M, Teshima T; Japan Study Group for Cell Therapy and Transplantation. Sugita J, et al. Biol Blood Marrow Transplant. 2015 Sep;21(9):1646-52. doi: 10.1016/j.bbmt.2015.06.008. Epub 2015 Jun 18. Biol Blood Marrow Transplant. 2015. PMID: 26093044 Free article. Clinical Trial.
Occurrence of adverse events caused by valganciclovir as pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation is reduced by low-dose administration.
Takahata M, Hashino S, Nishio M, Sugita J, Shigematsu A, Onozawa M, Fujimoto K, Endo T, Kondo T, Tanaka J, Imamura M, Teshima T. Takahata M, et al. Among authors: sugita j. Transpl Infect Dis. 2015 Dec;17(6):810-5. doi: 10.1111/tid.12456. Epub 2015 Nov 5. Transpl Infect Dis. 2015. PMID: 26354293
191 results